These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4816171)
1. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Kirkpatrick CH; Smith TK Ann Intern Med; 1974 Mar; 80(3):310-20. PubMed ID: 4816171 [No Abstract] [Full Text] [Related]
2. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Kirkpatrick CH; Rich RR; Bennett JE Ann Intern Med; 1971 Jun; 74(6):955-78. PubMed ID: 4931743 [No Abstract] [Full Text] [Related]
3. Treatment of mucocutaneous candidasis with transfer factor. Feigin RD; Shackelford PG; Eisen S; Spitler LE; Pickering LK; Anderson DC Pediatrics; 1974 Jan; 53(1):63-70. PubMed ID: 4588132 [No Abstract] [Full Text] [Related]
4. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Schulking ML; Adler WH; Altemeier WA; Ayoub EM Cell Immunol; 1972 Apr; 3(4):606-15. PubMed ID: 4554089 [No Abstract] [Full Text] [Related]
5. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Paterson PY; Semo R; Blumenschein G; Swelstad J Clin Exp Immunol; 1971 Nov; 9(5):595-602. PubMed ID: 4947556 [TBL] [Abstract][Full Text] [Related]
6. [Immunological defence and transfer factor therapy in chronic mucocutaneous candidiasis]. Bläker F; Grob PJ; Hellwege HH; Schulz KH Dtsch Med Wochenschr; 1973 Mar; 98(9):415-20. PubMed ID: 4691560 [No Abstract] [Full Text] [Related]
7. [Diffuse chronic mucocutaneous candidiasis: Effects of antimycotics in vitro]. Ottolenghi F; Andreassi L; Sbano E; Fimiani M Hautarzt; 1975 May; 26(5):260-3. PubMed ID: 1150440 [No Abstract] [Full Text] [Related]
8. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Rocklin RE; Chilgren RA; Hong R; David JR Cell Immunol; 1970 Sep; 1(3):290-9. PubMed ID: 5523582 [No Abstract] [Full Text] [Related]
9. Transfer factor as an approach to the treatment of immune deficiency disease. Schulkind ML; Ayoub EM Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988 [TBL] [Abstract][Full Text] [Related]
11. Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. Maize JC; Lynch PJ Arch Dermatol; 1972 Jan; 105(1):96-8. PubMed ID: 5009626 [No Abstract] [Full Text] [Related]
12. [Chronic mucocutaneous moniliasis. Immunological clinical study of a case and trial treatment with the transfer factor]. Touraine JL; Freycon F; Kraft O; Betuel H; Freycon MT; Larbre F Pediatrie; 1973; 28(3):271-81. PubMed ID: 4726384 [No Abstract] [Full Text] [Related]
13. Chronic mucocutaneous candidiasis. Immunologic evaluation and therapy. South MA Cutis; 1977 Mar; 19(3):275, 279, 281, 283. PubMed ID: 844330 [No Abstract] [Full Text] [Related]
14. Treatment of chronic muco-cutaneous candidiasis by lymphocyte transfer factor. Jose DG Aust N Z J Med; 1975 Aug; 5(4):318-23. PubMed ID: 1058670 [TBL] [Abstract][Full Text] [Related]
15. [Partial deficiency of cell-mediated immunity in a child with chronic mucocutaneous candidiasis. Intercurrent meningeal and pulmonary cryptococcosis]. Gerbeaux J; Baculard A; Tournier G; Moulias R; Goust JM; Drouhet Ed; Saint-Martin J Ann Med Interne (Paris); 1975; 126(8-9):623-4. PubMed ID: 1217770 [TBL] [Abstract][Full Text] [Related]
16. An evolution of therapy for mucocutaneous candidiasis. Kornblut AD Laryngoscope; 1980 Jul; 90(7 Pt 2 Suppl 22):1-30. PubMed ID: 7382716 [TBL] [Abstract][Full Text] [Related]
17. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Valdimarsson H; Wood CB; Hobbs JR; Holt PJ Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179 [TBL] [Abstract][Full Text] [Related]